Mathew Martoma, who begins trial tomorrow, won several rulings limiting the evidence prosecutors may use to try to prove he made $276M for SAC based on inside information. (Bloomberg) — Prosecutors in ...
The money was left over from SAC's $602 million settlement in March 2013 with the U.S. Securities and Exchange Commission over trades in drugmakers Wyeth and Elan by Mathew Martoma, who worked at ...
CR Intrinsic has previously employed Mathew Martoma, a portfolio manager who was charged with insider trading by the SEC earlier this year. CR Intrinsic's $600 million settlement was the largest ...
NEW YORK (Reuters) - Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider trading settlement involving billionaire Steven A.
The money was left over from SAC's $602 million settlement in March 2013 with the U.S. Securities and Exchange Commission over trades in drugmakers Wyeth and Elan by Mathew Martoma, who worked at an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results